Veterinary Medicines

NEKRO VEYXYM

Authorised
  • Chymotrypsin
  • Trypsin
  • Papain
Download as PDF

Product identification

Medicine name:
NEKRO VEYXYM
Active substance:
  • Chymotrypsin
  • Trypsin
  • Papain
Target species:
  • Cattle
  • Sheep
  • Goat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Chymotrypsin
    1200.00
    FIP
    /
    1.00
    millilitre(s)
  • Trypsin
    120.00
    FIP
    /
    1.00
    millilitre(s)
  • Papain
    15.00
    FIP
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Sheep
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Goat
      • Milk
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD03B
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Available in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 120142
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 26/10/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."